* BioLife Solutions Inc BLFS.OQ reported a quarterly
adjusted
loss of 23 cents per share for the quarter ended in June. The
mean expectation of eight analysts for the quarter was for a
loss of 20 cents per share.
* Revenue fell 2.5% to $39.51 million from a year ago;
analysts
expected $43.86 million.
* BioLife Solutions Inc's reported EPS for the quarter was a
loss
of 23 cents.
* The mean earnings estimate of analysts had fallen by
about 12.9%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* BioLife Solutions Inc shares had fallen by 15.7% this
quarter and gained 2.4% so far this year.
* The company reported a quarterly loss of $10.2 million.
* Wall Street's median 12-month price target for BioLife
Solutions
Inc is $30.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 8 at 10:08 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.20 -0.23 Missed
Mar. 31 2023 -0.21 -0.32 Missed
Dec. 31 2022 -0.17 -1.15 Missed
Sep. 30 2022 -0.17 -0.23 Missed